Every round on record, with the sources behind each and the investors on them.
A medical device company developing magnetic technology for gastrointestinal surgery
gtmetabolic.comLinkedInMinneapolis, MinnesotaFounded 2020
10 sources · checked 1 time, last 11m ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The amount was not disclosed; no financing total or valuation is stated.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C | n/a | 2026-10-28 | J.P. Morgan Life Sciences Private Capital | 3 outlets. #75 in Trending |
10 sources · checked 1 time, last 11m ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 10 sources The amount was not disclosed; no financing total or valuation is stated. | ||||
GT Metabolic Solutions builds magnetic, incisionless devices that help bariatric, metabolic, and digestive surgeons create gastrointestinal connections without cutting, suturing, or stapling.
GT Metabolic is addressing a difficult problem in gastrointestinal surgery: conventional anastomoses can lead to leaks and bleeding, while its magnetic approach is designed to form connections gradually without bowel incisions or permanent foreign material. The company has obtained FDA De Novo and 510(k) clearances and completed first U.S. cases, while its October 2026 Series C from J.P. Morgan is intended to fund global commercialization and expansion into endoscopic and colorectal indications.
Checked against 10 sources